
Pharmaceutical Regulatory Affairs Masterclass
Regulatory Affairs is one of the most important functions in the pharmaceutical and biotechnology industries. It ensures that drugs are developed, manufactured, and marketed in compliance with regulatory guidelines and global health authorities.
This comprehensive course is designed to provide a strong foundation in Pharmaceutical Regulatory Affairs, covering the complete regulatory lifecycle of drug development and approval.
In this course, you will learn the key concepts, regulatory frameworks, and submission processes used by regulatory agencies such as the FDA. The course explains the entire journey of a pharmaceutical product—from early development stages to regulatory approval and post-marketing compliance.
We begin with the fundamentals of regulatory affairs, including important terminology, objectives, and the role of regulatory professionals in pharmaceutical companies. You will then explore the drug development process, including preclinical research, clinical trials, and regulatory submissions such as IND, NDA, and ANDA.
The course also explains critical regulatory documentation including Drug Master Files (DMF) and the Common Technical Document (CTD) format used globally for regulatory submissions. You will gain a clear understanding of electronic submissions (eCTD) and the differences between various regulatory pathways.
In addition, the course covers important compliance topics such as Good Manufacturing Practices (GMP) and regulatory strategy used to successfully bring pharmaceutical products to market.
By the end of this course, you will have a clear understanding of how regulatory affairs works in the pharmaceutical industry and how drugs are approved by regulatory authorities.
This course is ideal for students, pharmacy graduates, life science professionals, and anyone interested in building a career in regulatory affairs.